Regeneron Pharmaceuticals Long Term Debt to Equity vs PPandE Turnover Analysis

REGN -- USA Stock  

Quarterly Earning Report: November 5, 2019  

Regeneron Pharmaceuticals financial indicator trend analysis is much more than just breaking down Regeneron Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Regeneron Pharmaceuticals is a good investment. Please check the relationship between Regeneron Pharmaceuticals Long Term Debt to Equity and its PPandE Turnover accounts. Additionally take a look at Your Equity Center.

Long Term Debt to Equity vs PPandE Turnover

Accounts Relationship

Long Term Debt to Equity vs PPandE Turnover

Significance: Significant Contrarian Relationship

Long Term Debt to Equity diversification synergy
Overlapping area represents amount of trend that can be explained by analyzing historical patterns of Regeneron Pharmaceuticals Long Term Debt to Equity account and PPandE Turnover

Correlation Coefficient

-0.44
Relationship DirectionNegative 
Relationship StrengthVery Weak

Long Term Debt to Equity

PPandE Turnover

Search macroaxis.com